Announcements Trials

Browse Landscape

Status

Not yet recruiting 3 Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1789 Neoplasms 1516 Carcinoma, Non-Small-Cell Lung 1053 Prostatic Neoplasms 965 Colorectal Neoplasms 889 Lung Neoplasms 809 Pancreatic Neoplasms 583 Carcinoma, Hepatocellular 543 Leukemia, Myeloid, Acute 540 Stomach Neoplasms 523 Ovarian Neoplasms 513 Neoplasm Metastasis 492 Multiple Myeloma 491 Recurrence 417 Melanoma 390 Squamous Cell Carcinoma of Head and Neck 374 Uterine Cervical Neoplasms 366 Brain Neoplasms 364 Head and Neck Neoplasms 355 Esophageal Neoplasms 320 Precursor Cell Lymphoblastic Leukemia-Lymphoma 313 Endometrial Neoplasms 311 Lymphoma 309 Triple Negative Breast Neoplasms 301 Glioblastoma 298 Rectal Neoplasms 284 Urinary Bladder Neoplasms 268 Sarcoma 266 Hematologic Neoplasms 266 Colonic Neoplasms 257

Interventions

Platinum Compounds 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Resectable Non-small Cell Lung Cancer × Clear all

NCT06169956 2024-04-18

NENI

Bristol-Myers Squibb

Resectable Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡